Rhodia Wins the Potier Prize for Innovation in Favour of the Environment

Paul-Joël Derian, Rhodia Vice President, Research & Development, has received from François Loos, Minister Delegate for Industry in the French Government, the Pierre Potier Prize in the “Process” category in recognition of the CAPUCINE initiative developed by Rhodia for the synthesis of caprolactam, an intermediate used in the production of polyamide 6.

The Potier Prize, created by the Minister Delegate for Industry, the French Federation of Chemical Companies (FCC) and the UIC French chemical industry association, was organized in 2006 on the theme of “Innovation in chemistry in favor of the environment” in order to promote industrial success stories achieved recently (2004-2005) or in the final stages of completion.

This prize, awarded by a panel chaired by Yves Chauvin, winner of the 2005 Nobel Prize for Chemistry, in the presence of Armand Lattes, Chairman of the FCC and of the French Chemical Society (SFC), was given to Rhodia’s teams as official recognition of their outstanding scientific and technical achievement in developing a new access route to caprolactam via heterogeneous catalysis. This simple, original and flexible process leads to this intermediate without the formation of by-products and at a highly competitive production price compared with other available technologies.

This patented innovation, which will allow Rhodia to develop a cost-effective process in line with the Group’s commitments to sustainable development, will make it possible to eliminate the disadvantages of the traditional production process, namely: the generation of saline by-products and the use of solvents. This innovation will generate no nitrogen oxides (a greenhouse gas) and allow energy savings of 50%.

“The success of this project demonstrates the Group’s ability to include environmental considerations in its innovation programs in order to find solutions to true technological challenges,” said Paul-Joël Derian, Rhodia Vice President, Research & Development.

http://www.rhodia.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.